Pre-filled syringe simplifies delivery

Published: 1-Feb-2005


Britannia Pharmaceuticals has announced the availability of the APO-go Pre-Filled Syringe (PFS), an easier to use presentation for Parkinson's disease patients using apomorphine by continuous infusion with an APO-go pump.

The new APO-go PFS contains a 5mg/ml concentration of apomorphine hydrochloride, which is ready for transfer to a plastic syringe specifically designed for use with an APO-go pump, thus reducing the time of the preparation procedure.

The other main advantages of the PFS include: reduced likelihood of spillage or contamination; accurate dosage thanks to pre-dilution; no need to break ampoules, thereby eliminating associated risk; and lower cost to the NHS compared with separate APO-go and saline ampoules.

You may also like